Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

SUMMARY BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) poses an important challenge in TB management and control. Rifampicin resistance (RR) is a solid surrogate marker of MDR-TB. We investigated the RR-TB clustering rates, bacterial population dynamics to infer transmission dynamics, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngabonziza, Jean Claude S., Rigouts, Leen, Torrea, Gabriela, Decroo, Tom, Kamanzi, Eliane, Lempens, Pauline, Rucogoza, Aniceth, Habimana, Yves M., Laenen, Lies, Niyigena, Belamo E., Uwizeye, Cécile, Ushizimpumu, Bertin, Mulders, Wim, Ivan, Emil, Tzfadia, Oren, Muvunyi, Claude Mambo, Migambi, Patrick, Andre, Emmanuel, Mazarati, Jean Baptiste, Affolabi, Dissou, Umubyeyi, Alaine N., Nsanzimana, Sabin, Portaels, Françoise, Gasana, Michel, de Jong, Bouke C., Meehan, Conor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802117/
https://www.ncbi.nlm.nih.gov/pubmed/35146133
http://dx.doi.org/10.1016/j.jctube.2022.100299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802117/
https://www.ncbi.nlm.nih.gov/pubmed/35146133
http://dx.doi.org/10.1016/j.jctube.2022.100299

Ejemplares similares